Chronic intake of high-fat and high-sucrose diets differentially affects glucose intolerance in mice

Journal of Nutrition

Volumn 136, Issue 3, 2006, Pages 582-587

  Sumiyoshi, Maho ^a   Sakanaka, Masahiro ^a   Kimura, Yoshiyuki ^b  

^a Department of Integrated Basic Medical Science ^*

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glucose intolerance; High fat; High sucrose; Lean; Obesity

Indexed keywords

FAT; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; SUCRASE; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FAT INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; HYPERLEPTINEMIA; HYPERLIPIDEMIA; INSULIN RELEASE; INSULIN RESISTANCE; LIPOGENESIS; MACRONUTRIENT; MALE; METABOLIC DISORDER; MOUSE; MOUSE STRAIN; NONHUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PATHOGENESIS; SMALL INTESTINE; SUGAR INTAKE; WEIGHT GAIN;

ANIMALIA;

EID: 33644835583     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.3.582     Document Type: Article

References (45)

1. Plutzky J. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol. 2000;15:416-21.
2. Reaven GM. Role of insulin resistance on human disease. Diabetes. 1988;37:1595-607.
3. Axen KV, Dikeakos A, Sclafani A. High dietary fat promotes Syndrome X in nonobese rats. J Nutr. 2003;133:2244-9.
4. Bessesen DH. The role of carbohydrates in insulin resistance. J Nutr. 2001;131:2782S-6.
5. Harris RB, Kor H. Insulin sensitivity is rapidly reversed in rat by dietary fat from 40% to 30% of energy. J Nutr. 1992;122:1811-22.
6. Storlien LH, Kraegen EW, Jenkins AB, Chisholm DJ. Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats. Am J Clin Nutr. 1988;47:420-7.
7. Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ. Development of hypertension in a rat model of diet-induced obesity. Hypertension. 2000;35:1009-15.
8. Mann JI. Diet and risk of coronary heart diseases and type2 diabetes. Lancet. 2002;360:783-9.
9. Fried SK, Rao SP. Sugar, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr. 2003;78:873S-80.
10. Ahren B, Scheurink AJ. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol. 1998;139:461-7.
11. Brenner RR, Rimoldi OJ, Lombardo YB, Gonzalez MS, Bernasconi AM, Chicco A, Basabe JC. Desaturase activities in rat model of insulin resistance induced by a sucrose-rich diet. Lipids. 2003;38:733-42.
12. Muurling M, Jong MC, Mensink RP, Hornstra G, Dahlmans VEH, Pijl H, Voshol PJ, Havekes LM. A low-fat diet has a higher potential than restriction to improve high-fat diet-induced insulin resistance in mice. Metabolism. 2002;51:695-701.
13. Pagliassotti MJ, Prach P, Koppenhafer T, Pan DA. Changes in insulin action, triglycerides, and lipid composition during sucrose feeding in rats. Am J Physiol Regul Integr Comp Physiol. 1996;271:R1319-26.
14. Ryu MH, Cha YS. The effects of high-fat or high-sucrose diet on serum lipid profiles, hepatic acyl-CoA synthetase, carnitine palmitoyltransferase-I, and the acetyl-CoA carboxylase mRNA levels in rats. J Biochem Mol Biol. 2003;36:312-8.
15. Arner P. Insulin resistance in type 2 diabetes: role of fatty acid. Diabetes Metab Res Rev. 2002;18:S5-9.
16. Tomas E, Lin YS, Dagher Z, Saha A, Luo Z, Ido Y, Ruderman NB. Hyperglycemia and insulin resistance: possible mechanisms. Ann N Y Acad Sci. 2002;967:43-51.
17. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-81.
18. Harte RA, Kirk EA, Rosenfeld ME, LeBoeuf RC. Initiation of hyperinsulinemia and hyperleptinemia is diet dependent in C57BL/6 mice. Horm Metab Res. 1999;31:570-5.
19. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN. Diet-induced typeII diabetes in C57BL/6J mice. Diabetes. 1988;37:1163-7.
20. Surwit RS, Feinglos MN, Rodin J, Sutherland A, Petro AE, Opara EC, Kuhn CM, Rebuffe-Scrive M. Differential effects of fat and sucrose on development of obesity and diabetes in C57BL/6J and A/j mice. Metabolism. 1995;44:645-51.
21. American Institute of Nutrition. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J Nutr. 1977;107:1340-8.
22. Fletcher MJ. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968;22:393-7.
23. Zak B, Dickman RC, White EG, Cherney PJ. Rapid estimation of free and total cholesterol. Am J Clin Pathol. 1954;24:1307-15.
24. Iverius PH, Ostrund-Lindqvist AM. Preparation, characterization, and measurement of lipoprotein lipase. Methods Enzymol. 1986;129:691-704.
25. Han LK, Kimura Y, Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int J Obes. 1999;23:174-9.
26. Daniele N, Rajas F, Payrastre B, Mauco G, Zitoun C, Mithieux G. Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6-phosphatase during refeeding. J Biol Chem. 1999;274:3597-601.
27. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem. 1925;66:375-400.
28. Shapiro DJ, Imblum RL, Rodwell VW. Thin-layer chromatographic assay for HMG-CoA reductase and mevalonic acid. Anal Biochem. 1969;31:383-90.
29. Tijburg LB, Maquedano A, Bijleveld C, Guzman M, Geelen MJH. Effects of ethanol feeding on hepatic lipid synthesis. Arch Biochem Biophys. 1988;267:568-79.
30. Dahlqvist A. Method for assay of intestinal disaccharidases. Anal Biochem. 1964;57:18-25.
31. Itoh Y, Kawamata Y, Harada M, Kobayash M, Fujii R, Fukusumi S, Ogi K, Hosoya M, Tanaka Y, et al. Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40. Nature. 2003;422:173-6.
32. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alternations in the insulin signaling cascade. Diabetes. 1999;48:1270-4.
33. Hegarty BD, Furler SM, Ye J, Cooney GJ. Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand. 2003;178:373-83.
34. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Wakai H, Uchida S, Yamashita S, Noda M, Kita S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002;8:1288-95.
35. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
36. Baratta R, Amato S, Degano C, Farina MG, Patané G, Vigneri R, Frittitta L. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J Clin Endocrinol Metab. 2004;89:2665-71.
37. Hoffstedt J, Arvidsson E, Sjölin E, Wåhlén K, Arner P. Adipose tissue adiponectin production and adiponectin serum concentration in human obesity and insulin resistance. J Clin Endocrinol Metab. 2004;89:1391-6.
38. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Hormonal regulation of the diurnal rhythm of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in rat liver by insulin, glucagons, cyclic AMP and hydrocortisone. Arch Biochem Biophys. 1974;160:387-93.
39. Najjar SM, Yang Y, Fernström MA, Lee SA, DeAngelis AM, Rijaily GAA, Al-Share QY, Dai T, Miller TA, et al. Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab. 2005;2:43-53.
40. Ookuma M, Ookuma K, York DA. Effects of leptin on insulin secretion from isolated rat pancreatic islets. Diabetes. 1998;47:219-23.
41. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-7.
42. Egashira K. Molecular mechanisms mediating inflammation in vascular disease. Hypertension. 2003;41:834-41.
43. Kusano KF, Nakamura K, Kusano H, Nishii N, Banba K, Ikeda T, Hashimoto K, Yamamoto M, Fujio H, et al. Significance of the level of monocyte chemoattractant protein-1 in human atherosclerosis. Circ J. 2004; 68: 671-6.
44. Sartipy P, Losktoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A. 2003;100:7265-70.
45. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-808.